AZD8683 Multiple Dose Study in Healthy Volunteers and Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01584739 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: AZD8683
DRUG: Placebo

Sponsor

AstraZeneca